• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性骨化性纤维发育不良开始为人所知。

Fibrodysplasia ossificans progressiva emerges from obscurity.

作者信息

Kaplan Frederick S, Shore Eileen M, Pignolo Robert J

机构信息

Department of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Research in FOP and Related Disorders, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

Department of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

出版信息

Trends Mol Med. 2025 Feb;31(2):106-116. doi: 10.1016/j.molmed.2024.08.010. Epub 2024 Sep 18.

DOI:10.1016/j.molmed.2024.08.010
PMID:39299836
Abstract

Fibrodysplasia ossificans progressiva (FOP), a disorder of congenital skeletal malformations and progressive extraskeletal ossification, is the most severe form of heterotopic ossification (HO) in humans. Gain-of-function pathogenic variants in activin A receptor type I (ACVR1), a bone morphogenetic protein (BMP) type 1 receptor, cause FOP by dramatically altering the normal physiologic functions of ACVR1, impacting BMP signaling and other interacting pathways. These alterations affect various systems, including inflammation, innate immunity, hypoxia sensing, wound healing, aging, temperature and mechanical thresholds, pain sensitivity, skeletal growth, diarthrodial joint patterning, joint function and fate, and HO. This article examines the emergent properties of FOP's diverse phenotypes, proposes a schema for targeting these phenotypes, and highlights outstanding questions and knowledge gaps.

摘要

进行性骨化性纤维发育不良(FOP)是一种先天性骨骼畸形和进行性骨外骨化疾病,是人类最严重的异位骨化(HO)形式。激活素A受体I型(ACVR1)是一种骨形态发生蛋白(BMP)1型受体,其功能获得性致病变异通过显著改变ACVR1的正常生理功能、影响BMP信号传导和其他相互作用途径而导致FOP。这些改变影响各种系统,包括炎症、先天免疫、缺氧感知、伤口愈合、衰老、温度和机械阈值、疼痛敏感性、骨骼生长、双关节模式、关节功能和命运以及异位骨化。本文研究了FOP多种表型的新特性,提出了针对这些表型的方案,并强调了突出问题和知识空白。

相似文献

1
Fibrodysplasia ossificans progressiva emerges from obscurity.进行性骨化性纤维发育不良开始为人所知。
Trends Mol Med. 2025 Feb;31(2):106-116. doi: 10.1016/j.molmed.2024.08.010. Epub 2024 Sep 18.
2
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.在进行性骨化性纤维发育不良中,激活素 A 在异位骨形成中的必然作用。
Bone. 2018 Apr;109:210-217. doi: 10.1016/j.bone.2017.06.011. Epub 2017 Jun 16.
3
The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.在进行性骨化性纤维发育不良中发现的ACVR1 R206H突变通过BMP介导的SMAD1/5/8信号通路增加人诱导多能干细胞衍生的内皮细胞形成和胶原蛋白生成。
Stem Cell Res Ther. 2016 Aug 17;7(1):115. doi: 10.1186/s13287-016-0372-6.
4
Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1 Mouse Model of Fibrodysplasia Ossificans Progressiva.破骨细胞和巨噬细胞耗竭可损害 Acvr1 小鼠纤维性骨发育不良进展性异位骨化模型中的异位骨化。
J Bone Miner Res. 2018 Feb;33(2):269-282. doi: 10.1002/jbmr.3304. Epub 2018 Jan 3.
5
BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).骨纤维发育不良性骨化症(FOP)中的 BMP 信号和骨骼发育。
Dev Dyn. 2022 Jan;251(1):164-177. doi: 10.1002/dvdy.387. Epub 2021 Jun 26.
6
Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.野生型 ACVR1 在进行性骨化性纤维发育不良小鼠中的过表达可挽救围产期致死性并抑制异位骨化。
J Bone Miner Res. 2022 Nov;37(11):2077-2093. doi: 10.1002/jbmr.4617. Epub 2022 Jul 3.
7
Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.纤维性骨发育不良性骨化性纤维发育不良中必需因子转录调控的提示。
Bone. 2018 Apr;109:187-191. doi: 10.1016/j.bone.2017.10.028. Epub 2017 Oct 31.
8
Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1 -Specific Human Cellular and Zebrafish Models.全外显子测序鉴定的骨形态发生蛋白(BMP)通路变异在迟发性进行性骨化性纤维发育不良(FOP)患者中的功能检测:使用 ACVR1 特异性人细胞和斑马鱼模型。
J Bone Miner Res. 2022 Nov;37(11):2058-2076. doi: 10.1002/jbmr.4711. Epub 2022 Nov 15.
9
Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice.基质金属蛋白酶-9缺乏赋予一名男性和小鼠对进行性骨化性纤维发育不良的抵抗力。
J Bone Miner Res. 2024 May 2;39(4):382-398. doi: 10.1093/jbmr/zjae029.
10
Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification.激活素受体样激酶2(Alk2)在进行性骨化性纤维发育不良的异位软骨内骨化过程中调节早期软骨形成命运。
Stem Cells. 2014 May;32(5):1289-300. doi: 10.1002/stem.1633.

引用本文的文献

1
Macrophage Polarization in Heterotopic Ossification: Inflammation, Osteogenesis, and Emerging Therapeutic Targets.异位骨化中的巨噬细胞极化:炎症、骨生成及新兴治疗靶点
Int J Mol Sci. 2025 Jun 17;26(12):5821. doi: 10.3390/ijms26125821.
2
A new BMP type 1 receptor kinase inhibitor for safe and efficient oral treatment to prevent genetically induced heterotopic ossification in mice.一种新型BMP 1型受体激酶抑制剂,用于安全有效的口服治疗,以预防小鼠基因诱导的异位骨化。
Bone. 2025 Oct;199:117565. doi: 10.1016/j.bone.2025.117565. Epub 2025 Jun 18.
3
FOP: From Biomolecules to Hope.
进行性骨化性纤维发育不良:从生物分子到希望
Biomolecules. 2025 Feb 24;15(3):328. doi: 10.3390/biom15030328.
4
Targeting to BMP9 to restrain flare-up of fibrodysplasia ossificans progressiva.靶向骨形态发生蛋白9以抑制进行性骨化性纤维发育不良的发作。
EMBO Mol Med. 2025 Jan;17(1):1-2. doi: 10.1038/s44321-024-00180-5. Epub 2024 Dec 3.